https://www.selleckchem.com/products/mrt68921.html
1%; p = 0.621) in patients undergoing UKA. However, the rate of patients with dyspnea, (5.7% versus 3.6%; p 0.001), anemia (9.4 versus 7.3%; p 0.001), and overall morbidity/mortality probability have improved, with a decrease in hospital LOS (2.2 ± 1.9days versus 1.4 ± 2.1days; p 0.001) and an increase in home-discharge (90.7% versus 95.2%; p 0.001). From 2008 to 2018, there was minimal improvement in UKA patients' modifiable comorbidities. However, despite the lack of significant change in patient health status, ou
Like
Comment
Share
